About
Solutions
Pipeline
Publications
News
Careers
Contact Us
en
Open main menu
News
Loading...
CN
Track Our News on
All
Press Release
Media Coverage
All
2025-06-19
2025-04-18
2025-03-07
2024-09-14
2024-07-29
2024-06-11
2024-05-22
2024-04-29
2024-04-15
2024-04-02
2024-03-20
2024-03-12
Previous
1 / 5
Next
Previous
1 / 5
Next
MindRank Announces Positive Phase 2b Results for AI-Designed Oral GLP-1 Receptor Agonist MDR-001 in Adults with Obesity or Overweight
Inform. Fusion | Adaptive symmetry-based adversarial perturbation augmentation for molecular graph representations with dual-fusion attention information
Dual WEE1/YES1 Kinase Inhibitor MRANK-106 Secures FDA IND Clearance, Positioning MindRank in First-in-Class Oncology Pipeline
Scientific Data | PharmaBench: Enhancing ADMET benchmarks with large language models
MindRank Begins IND-Enabling Studies of its AI-Designed Molecular Glue Drug Pipeline MRANK-103
MindRank Recognized in 2024 WAIC SAIL Award TOP30 List
MindRank and HISUN (600267.SH) Forge Strategic Partnership to Advance AI-Empowered Innovative Drug Discovery
MindRank Named as One of the Top 10 Emerging AI Tech Companies by Forbes China
MindRank Honored in Global Health & Pharma Magazine's 2024 Biotechnology Awards Winners
MindRank and BioMetas Announce Strategic Partnership to Establish One-Stop Service Platform for AI+ Drug Research and Development
News - MindRank
J. Cheminform. | Automated molecular structure segmentation from documents using ChemSAM
ChemRxiv | A Smart Strategy for Photoresponsive Molecules: Utilizing Generative Pre-trained Transformer and TDDFT Calculations in Drug Delivery
